[Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer].

Zhonghua wai ke za zhi [Chinese journal of surgery]

Volumn 48, Issue 7, 2010, Pages 530-534

  Wang, Shuang jia ^a   Sun, Bei ^b   Pan, Shang ha ^b   Chen, Hua ^b   Kong, Rui ^b   Li, Jun ^b   Xue, Dong bo ^b   Bai, Xue wei ^b   Jiang, Hong chi ^b  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; ARTEMISININ DERIVATIVE; DEOXYCYTIDINE; DIHYDROARTEMISININ; DRUG DERIVATIVE; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; DRUG EFFECT; DRUG SCREENING; HUMAN; MALE; METABOLISM; MOUSE; NUDE MOUSE; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; ARTEMISININS; CELL LINE, TUMOR; DEOXYCYTIDINE; HUMANS; MALE; MICE; MICE, NUDE; NF-KAPPA B; PANCREATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952780874     PISSN: 05295815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)